S.Amdt. 5619

SA 5619. Mr. LANKFORD submitted an amendment intended to be proposed to amendment SA 5499 submitted by Mr. Reed (for himself and Mr. Inhofe) and intended to be proposed to the bill H.R. 7900, to authorize appropriations for fiscal year 2023 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows:

At the end of subtitle F of title X, add the following:

SEC. 1064. REPORT ON PHARMACEUTICALS IMPORTED FROM THE PEOPLE'S REPUBLIC OF CHINA.

(a) In General.--Not later than 180 days after the date of the enactment of this Act, the Commissioner of Food and Drugs, in consultation with the United States Trade Representative, shall submit to the appropriate congressional committees a report that sets forth a list of--

(1) each finished pharmaceutical product that is imported into the United States from the People's Republic of China in a quantity that exceeds 20 percent of the quantity of the product available for use in the United States; and

(2) each active pharmaceutical ingredient that is imported into the United States from the People's Republic of China in a quantity that exceeds 20 percent of the quantity of the ingredient available for use in the United States.

(b) Appropriate Congressional Committees Defined.--In this section, the term “appropriate congressional committees” means--

(1) the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate; and

(2) the Committee on Energy and Commerce and the Committee on Ways and Means of the House of Representatives.